SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. V. Filatova, A. Kh. Alieva, M. I. Shadrina, M. V. Shulskaya, E. Yu. Fedotova, S. N. Illarioshkin, S. A. Limborska, P. A. Slominsky, Analysis of mutations in patients with suspected autosomal dominant forms of Parkinson’s disease, Molecular Genetics, Microbiology and Virology, 2014, 29, 1, 1

    CrossRef

  2. 2
    Elena V. Filatova, Maria I. Shadrina, Ekaterina Y. Fedotova, Irina A. Ivanova-Smolenskaya, Sergei N. Illarioshkin, Svetlana A. Limborska, Petr A. Slominsky, Analysis of known point mutations and SNPs in genes responsible for monogenic Parkinson’s disease in Russian patients, Advances in Parkinson's Disease, 2013, 02, 01, 28

    CrossRef

  3. 3
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  4. 4
    L. Correia Guedes, J.J. Ferreira, M.M. Rosa, M. Coelho, V. Bonifati, C. Sampaio, Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review, Parkinsonism & Related Disorders, 2010, 16, 4, 237

    CrossRef

  5. 5
    M.I. Shadrina, P.A. Slominsky, S.A. Limborska, 2010,

    CrossRef

  6. 6
    Seyedmehdi Shojaee, Farzad Sina, Niloofar Farboodi, Zeinab Fazlali, Farzaneh Ghazavi, Seyed Ali Ghorashi, Khosro Parsa, Homa Sadeghi, Gholam-Ali Shahidi, Mostafa Ronaghi, Elahe Elahi, A clinic-based screening of mutations in exons 31, 34, 35, 41, and 48 of LRRK2 in Iranian Parkinson's disease patients, Movement Disorders, 2009, 24, 7
  7. 7
    Avner Thaler, Elissa Ash, Ziv Gan-Or, Avi Orr-Urtreger, Nir Giladi, The LRRK2 G2019S mutation as the cause of Parkinson’s disease in Ashkenazi Jews, Journal of Neural Transmission, 2009, 116, 11, 1473

    CrossRef

  8. 8
    M. I. Shadrina, P. A. Slominsky, Mitochondrial dysfunction and oxidative damage in the molecular pathology of Parkinson’s disease, Molecular Biology, 2008, 42, 5, 720

    CrossRef

  9. 9
    S. N. Pchelina, A. F. Yakimovskii, A. K. Emelyanov, O. N. Ivanova, A. L. Schwarzman, A. B. Singleton, Screening for LRRK2 mutations in patients with Parkinson’s disease in Russia: identification of a novel LRRK2 variant, European Journal of Neurology, 2008, 15, 7